The report "Udder Health Market by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Global Forecast to 2029", is projected to reach USD 1.6 billion by 2029 from USD 1.2 billion in 2024 at a CAGR of 5.9%.
Browse 295 market data Tables and 65 Figures spread through 290 Pages and in-depth TOC on "Udder Health Market by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/udder-health-market-76741813.html
The growth in this market is mainly driven by several factors, including the rising number of veterinary practitioners in developed countries and the increasing prevalence of mastitis and other udder health issues in dairy cows. Technological advancements in udder health monitoring are also playing a significant role. These advancements include innovative diagnostic tools and treatment methods, which help in early detection and effective management of udder health problems. Additionally, growing awareness among dairy farmers about the importance of udder health for milk quality and production is further boosting the market.
“Based on product, the devices segment is expected to witness the fastest CAGR in the udder health market.”
In the forecast period, the devices segment is expected to witness the fastest CAGR in the global udder health market. This high growth rate can be attributed to the increasing incidence of mastitis and other udder health disorders, which necessitate effective monitoring and treatment solutions. Technological advancements in udder health monitoring devices, such as more accurate sensors and automated systems, have greatly improved early detection and management of these issues. Additionally, rising governmental support, including funding and initiatives to improve animal health, has further strengthened this segment's substantial presence in the market. These efforts ensure better healthcare infrastructure and resources for dairy farmers, ultimately enhancing the adoption and effectiveness of advanced udder health devices. These factors emphasis the dominance of the devices segment in the market.
“On the basis of veterinary care setting, dairy farms segment in the udder health market has accounted the largest share in the forecast period.”
Based on veterinary care settings, the dairy farms segment of the udder health market accounted the largest market share in the forecast period. This growth is subjected to innovations such as early detection tools and efficient treatments are increasingly being adopted to manage and prevent mastitis effectively. Additionally, the economic importance of maintaining healthy cattle and ensuring optimal milk yield drives the demand for these advanced udder health products, securing the dairy farm segment's dominant position in the market.
“Based of animal type, dairy cattle holds the highest market share in the udder health market.”
Dairy cattle segment secures the highest market share in the udder health market. The leading position of dairy cattle in the udder health market is driven by multiple factors. Primarily, the high demand for milk production necessitates rigorous udder health maintenance to ensure both quality and yield. Additionally, dairy cattle are highly susceptible to udder-related ailments such as mastitis, creating a critical need for effective udder health solutions. Enhanced veterinary care and improved farm management techniques have also increased the focus on udder health among dairy farmers. Moreover, the economic implications of milk production losses due to udder diseases further propel the demand for udder health products in this segment. These factors collectively bolster the dairy cattle segment's prominence in the market.
“Based on Disease type, other disease types segment accounted the largest share in the udder health market.”
The largest share of the udder health market held by the other disease segment, including subclinical and chronic mastitis, is driven by the insidious nature and high prevalence of these conditions. Subclinical mastitis often goes undetected due to the absence of visible symptoms, leading to prolonged infection and substantial milk production losses. Chronic mastitis, with its persistent nature, also requires extensive management and treatment. The economic impact of reduced milk yield, increased veterinary costs, and the need for ongoing monitoring and intervention underscores the demand for effective diagnostic and therapeutic solutions, propelling the prominence of this segment in the udder health market.
“Based on Region, APAC is expected to witness the fastest CAGR in the under health during the forecast period.”
The growth in the region is due to several key factors. First, increasing dairy production and consumption in countries like India and China are driving the demand for udder health products to maintain livestock health and productivity. Second, raising awareness among farmers about the economic benefits of preventing udder diseases, such as mastitis, through proper health management is fostering adoption. These factors collectively influence the segment by creating a conducive environment for the adoption of udder health solutions, thereby accelerating market expansion in APAC.
Key Market Players:
Prominent players in the udder health market include Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]